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Abstract
Background: Climacteric stage women experience significant biological, psychological and social changes. With
demographic changes being observed in the growing number of climacteric stage women in Mexico, it is
important to improve their knowledge about the climacteric stage and its potential associated problems,
encourage their participation in screening programs, and promote the acquisition of healthy lifestyles.
At Mexican health care institutions the predominant health care model for climacteric stage women has a
biomedical perspective. Medical doctors provide mostly curative services and have limited support from other
health professionals. This study aims to design an integrative health care model (IHCM: bio-psycho-social,
multidisciplinary and women-centered) applicable in primary care services aimed at climacteric stage women.
Methods/Design: We present the design, inclusion criteria and detailed description of an IHCM. The IHCM consists
of collaborative and coordinated provision of services by a health team, which is involves a family doctor, nurse,
psychologist, and the woman herself. The health team promotes the empowerment of women through individual
and group counseling on the climacteric stage and health related self-care. The intervention lasts three months
followed by a three-month follow-up period to evaluate the effectiveness of the model. The effectiveness of the
model will be evaluated through the following aspects: health-related quality of life (HR-QoL), empowerment, self-
efficacy and knowledge regarding the climacteric stage and health-related self-care activities, use of screening
services, and improvement in lifestyles (regular leisure time physical activity and healthy diet).
Discussion: Participation in preventive activities should be encouraged among women in Mexico. Designing and
evaluating the effectiveness of an integrative health care model for women at the climacteric stage, based on the
empowerment approach and focus on health-related self-care to improve their HR-QoL is pertinent for current
health conditions of this age group.
Trial registration: The study is registered at the ClinicalTrials.gov (NCT01272115).
Background
The climacteric stage is the transition from the repro-
ductive to the non-reproductive period during a
woman’s life [1], and comprises 2 to 8 years before and
after menopause [2], and coincides with a complex per-
iod in life due to biological, psychological and social
changes.
Two circumstances motivated the design of this study.
One is related to the unfelt and unsatisfied health needs
of climacteric stage women; the other is related to the
existing supply of health services in Mexico to the care
of women at this stage.
Health needs and existing supply of health services in
Mexico for climacteric stage women
A need arises when one sees a difference between the
situation considered as optimal and the actual observed
s i t u a t i o n ;t h ed i f f e r e n c et ob er e d u c e di st h e nt h en e e d .
In the health field, the felt need relates to the perception
people have about their health problems or whatever
they want to receive from the health services. Unlike a
need that is not felt, there exists a need that people do
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or improve their health [3].
Increase in life expectancy has also caused an increase
in the proportion of climacteric stage women with
respect to the general population. Traditionally, climac-
teric stage women seek medical attention when they
perceive health problems attributed to this stage such as
severe climacteric symptoms, osteoporosis-related frac-
tures, symptoms and/or complications of chronic dis-
eases. Regarding the unfelt and unsatisfied need, most
women do not perceive the need to prevent or detect
such health problems early. These situations result in
delayed health seeking-behavior for these problems,
which in turn represent a significant burden for health
care systems and for the society due to the high costs of
health care, decreased quali t yo fl i f ea n dp r e m a t u r e
death [4-6].
In Mexico, a high proportion of women in the climac-
teric stage experience important biological, psychological
and social changes; 50-70% report climacteric symptoms
[7,8], 45.6% depression and other mood and sleep disor-
ders [9], 31.1% suffer from hypertension, 16.7% suffer
from diabetes [10,11]; the prevalence of hip fractures
secondary to osteoporosis is 169 per 10,000 women-
years [12], of breast cancer is 27.4 per 100,000 woman-
years, and of cervical cancer is 19.2 per 100,000 woman-
years [13]. This situation is worsened by women’so v e r -
all limited knowledge about the potential health pro-
blems associated with the climacteric stage, and about
the necessary preventive measures, indicated by their
low participation in screening programs for chronic dis-
eases and their unhealthy lifestyles (high proportion of
physical inactivity and low consumption of fruits, vege-
tables and foods rich in calcium [8,11,14]), which
impede a better overall health and quality of life.
Regarding the existing supply of health care for cli-
macteric stage women (how the need is being met),
Mexico has a fragmented health system, composed by
Social Security institutions, the Ministry of Health
(MoH) and private providers. The Mexican Institute of
Social Security (IMSS) is a nation-wide social security
institution that provides health and social services as
well as economic benefits to formal sector workers and
their families (approximately 48 million). While the
MoH is central authority in charge of the policies and
design of programs and while the provision of care is
decentralized through the MoH in the 32 states, while
granting each a certain autonomy, MoH provides health
care to people without social security, mostly through
the System for Social Protection of Health [15].
Despite the existence of preventive programs, most
health care for climacteric women is based on a biome-
dical model in which a curative perspective predomi-
nates without support or with very limited support from
other health professionals, where the relationship
between health providers and patients is usually justified
by authoritative professional knowledge. This model
gives more importance to medical care for biological
symptoms and minimizes the relevance of the psychogi-
cal and social changes that happen during the climac-
teric period.
Interventions targeted at climacteric stage women
Most interventions for climacteric stage women have
focused on informing/educating women about prevent-
ing certain diseases. Some studies have developed edu-
cational strategies to prevent osteoporosis [16] or to
improve healthy diet [17], and have also aimed to
improve physical activity in menopausal women,
demonstrating the feasibility and effectiveness of moder-
ate and rigorous physical activity, which in turn
improves muscle strength, blood pressure, bone density
and health-related quality of life (HR-QoL) [18-20].
Other studies have examined the impact of information
about healthy behaviors, stress management and possi-
ble treatments during the climacteric stage; these studies
have reported the favorable effect of education groups
on the participants’ knowledge, which is manifested by
perceived ease in dealing with the changes of this stage,
increase of healthy habits and increased sexual interest,
when compared with a control group [21,22]. In climac-
teric women, as in the general population, interventions
that incorporate cognitive-behavioral strategies, such as
individual and group counseling to facilitate changes in
lifestyle, have greater positive effect on vasomotor symp-
toms, psychological distress, self-efficacy, satisfaction
with care and cardiovascular risk factors when com-
pared to printed or verbal information [23-28].
Integrative health care model and the empowerment
approach
In the 1980 s, the biomedical model was strongly criti-
cized in the middle of severe economic crises in many
countries including Mexico. Alternative models that
integrated biological, psychological and social areas
gained momentum [29]. In 1994, M. Flint [30], high-
lighted the relationship among the biological, social and
psychological factors that women face during meno-
pause, highlighting the need for women to receive bio-
psycho-social care at this stage.
The integrative health care model (IHCM) [31]
includes a multidisciplinary approach based on a non-
hierarchical combination of conventional medicine with
complementary and alternative medicine, which pro-
motes the harmonious continuity in decision-making
and care that should be focused on the patient. The
IHCM is based on a specific set of core values that
include the goal of addressing health care in a holistic
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The multidisciplinary approach of the IHCM is based
on the collaborative participation of health team mem-
bers, their mutual respect and a shared vision between
them and the patients. This circumstance allows each
provider and each patient to contribute their knowledge
and particular skills to focus on providing health care to
persons within individual care plans. In the experimental
field in both developed and developing countries,
attempts to implement the IHCM have been made. The
study results showed that the IHCM allowed increased
use of preventive services, improved health education
and health outcomes [32,33]. The integrative care model
is consistent with the empowerment approach. Empow-
erment is the social process of recognizing, promoting
and enhancing the capacity of people to meet their
needs, solve their problems, and mobilize the resources
needed to take control of their lives [34]. The goal of
patient empowerment is to build the patients’ capacity
for self-care, facilitate the process of obtaining experi-
ences to identify problems (health needs), set goals
related to their own health care, identify personal and
social obstacles, develop solutions, consider the possible
consequences of alternative solutions and make appro-
priate decisions for themselves [35-37]. The empower-
ment approach is linked to the theory of self-
determination which supports the empowering of
patients to be more independent in their self-care, and
raising the possibility of long-lasting changes in health-
related behaviors [38]. The counseling focused on the
problems perceived and prioritized by the individual
considers empowerment as an approach that also
includes cultural aspects.
Interventions aimed to potentiate individual (or social)
resources to prevent health damage or solve health pro-
blems implicitly adopt an empowerment approach to
enable people to improve their quality of life by increas-
ing the power to control their problems. For example, it
has been shown that individual and group counseling on
health-related self-care of patients with chronic diseases
based on the empowerment principles, taking their cul-
tural characteristics into account, achieved positive
effects on HR-QoL, knowledge about the disease and
related self-care, satisfaction with care and metabolic
control compared with the control group (telephone
counseling on metabolic control and traditional educa-
tion) [39,40]. In addition, patients empowered in health-
related self-care used fewer medical appointments,
resulting in significant savings for health services [41].
Conceptual model and objectives of the study
This framework sets the groundwork to address the
health needs of climacteric stage women through an
intervention that comprises, in an integral manner, their
bio-psycho-social needs (Figure 1) and allows women to
have greater control over the climacteric stage through
acquiring knowledge, building on and utilizing indivi-
dual strengths, making informed choices, setting perso-
nal goals, skills and attitudes necessary for better
management of their environment and health-related
self-care, which is called empowerment.
The characteristics of population, structure and pro-
cesses of care within social security allows the imple-
mentation and testing of an integrative health care
model (IHCM) for climacteric stage women (Table 1).
The lessons learned from this first intervention that will
be implemented in social security settings will provide
further elements and evidence to eventually propose a
study aimed at the population with social security in
other developing countries. This work aims to develop
an IHCM applicable in primary care services (family
medicine clinics) for climacteric stage women. The
effectiveness of the model will be evaluated through the
following aspects: a) improved HR-QoL; b-d) increased
empowerment, self-efficacy and knowledge regarding cli-
macteric stage, and health-related self-care activities; e)
increased use of screening services for breast cancer,
cervical cancer, diabetes and hypertension; f-g) improved
lifestyles: regular leisure time physical activity and
healthy diet.
Methods/Design
A field trial with one intervention and one comparison
group, with ex ante and ex post measurements will be
conducted in two IMSS primary care clinics in Mexico
City. The clinics will be selected for convenience; each
clinic must have more than 20 family doctors’ offices
and available space for the intervention (consulting
room and an area for group counseling) and should
have accepted to participate in the study; The interven-
tion will be conducted in one clinic and the other clinic
will serve as a comparison group, where the usual care
for climacteric stage women will be observed.
The study population will consist of women affiliated
with IMSS, between 45 and 59 years of age with a maxi-
mum of 5 years after menopause. The women should be
users of the clinic, and should not have mental condi-
tions that would prevent them from understanding the
information or from taking independent decisions
(dementia, mental retardation or psychosis), a physical
disability that would impede them from participating
(hearing loss, diseases affecting physical mobility as
severe forms of rheumatoid arthritis), medical diagnosis
of depression, diabetes mellitus, hypertension, renal or
liver failure, and/or cancer, because patients with these
diseases require specific care provided by several specia-
lists. All women must agree to participate in the study
through written informed consent.
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Preparation of the intervention
In both intervention and control clinics the project will
be presented to healthcare providers.
A healthcare team will implement the intervention
comprised of family doctors, two nurses (one for each
working shift) and a psychologist. The nurses and the
psychologist will be selected from those with clinical
experience in providing care to climacteric stage
women; they will be previously trained by researchers
and will work specifically in this project. The training
will include theory and practice, and will last 60 hours
based on a “training guide” that was developed ex pro-
feso. The training topics include: 1) Health needs of cli-
macteric stage women; 2) Risk factors for chronic
diseases during the climacteric stage and self-care-
related activities; 3) Health behaviors, self-efficacy,
knowledge regarding climacteric stage and health-related
self-care activities and empowerment; 4) Cognitive
restructuring and problem solving, self-esteem and
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Figure 1 Conceptual model of integrative health care for climacteric stage women.
Table 1 Structure and population characteristics of health institutions in Mexico
Mexican Institute of Social
Security
Ministry of Health
Population Formal sector workers and their
families
People without formal employment contracts, or unemployed and the
rural population
Organization Centralize Decentralize
Drug acquisition, laboratory and
screening tests
Covered by the social insurance Covered partially by the insurance + out of pocket payments
Medical doctors 1.4 per 1000 habitants 1.3 per 1000 habitants
Nurses 2.0 per 1000 habitants 1.7 per 1000 habitants
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vegetables and milk products; 6) Regular leisure time
with physical activity; 7) Individual counseling from the
empowerment approach. Self-care plan: goal setting,
action planning, monitoring and achievement of health
goals; 8) Group counseling from the empowerment; 9)
Integrative health care model for women at the climac-
teric stage.
All family doctors working in the intervention clinic
will be invited to participate in the study. Family doc-
tors, who agree to collaborate, will participate in a train-
ing course that consists in reviewing and discussing the
proposed model, the roles and responsibilities of health
providers involved in the care of climacteric stage
women within IHCM. The researchers will deliver this
course that will last two sessions of 60 minutes each.
Description of the intervention
The IHCM with an empowerment approach will address
the care that should be given collaboratively by the
health team in cooperation with the active participation
of women. The IHCM will be provided under the lea-
dership of the nurse who will coordinate with the health
team members, promote preventive care, and incorpo-
rate cognitive-behavioral strategies, such as individual
and group counseling. The IHCM will be provided for
three months to each woman, followed by a three-
month follow-up. The empowerment of women will
work to facilitate women’s recognition of their actual or
potential health problems, enable them to solve these
problems by drawing up an action plan to improve or
maintain their health, and develop their autonomous
health-related self-care skills.
In the control group, women will continue the usual
healthcare consisting of curative care provided by their
family doctor and preventive care according to the
IMSS prevention programs focused on this age group
(chronic disease screening) and provided by nurses
according to the women’s demand.
Recruitment of women and consultation with the family
doctor
In both working shifts (morning and afternoon) family
doctors will identify and evaluate those women who
meet the inclusion criteria. Family doctors should pro-
vide preventive and curative healthcare services, accord-
ing to womens’ individual health needs, and send the
candidates to the waiting room where they will be inter-
viewed by study interviewers, who will explain the pur-
pose and content of the study, and obtain the signed
informed consent from those women who agree to par-
ticipate. Once the participant is included in the study,
the interviewer will perform the base-line interview then
send the woman to the nurse of the study.
Individual counseling by nurse
Nurses will provide monthly individual counseling to
each woman based on the empowerment approach (the
first visit being 40 to 60 minutes with subsequent coun-
seling sessions of 20 to 30 minutes). The individual
counseling will include the following contents (Table 2):
1) the nurse and the woman collaboratively evaluating
the current status of the participant (physical, emotional,
cognitive and so forth) within their social environment;
2) the nurse facilitating the women’s recognition of her
personal health risks and responsibilities for health-
related self-care; 3) and 4) the nurse guiding the woman
in setting her health goals and laying out a feasible
action plan for her health-related self-care, thereby pro-
moting the empowerment of each participant; and 5)
the nurse and the woman collaboratively monitoring the
progress of the action plan.
The nurse will also schedule appointments for indivi-
dual and group counseling and refer the woman to the
psychologist and to the family doctor, who will provide
comprehensive and continuous care consistent with the
personal health needs of each participant.
Individual counseling by the psychologist
Psychological counseling will be based on the Rational
Emotive Behavioral Therapy and its central concept
ABC [42]. According to this concept, emotional and
behavioral consequences (C) are the result of beliefs (B)
on activating events (A). The psychologist and the
woman will collaboratively evaluate and restructure the
woman’s erroneous beliefs about the climacteric stage
and her emotional resources, which refer to the ability
to positively guide the emotions to achieve a better level
of self-esteem and self-efficacy. The psychologist and
the woman will define the number of consultations
required in accordance to her individual needs and
characteristics.
Group counseling
All women of the intervention group will be invited to
eight weekly, 90-minutes group sessions to facilitate and
enhance their knowledge about menopause and their
care, as well as to share experiences, concerns and moti-
vations, with other women. Each group session will be
coordinated by the nurse or psychologist of the study
and will include five to ten women. The group sessions
will focus on common educational needs. Both indivi-
dual and group counseling will be supported by printed
material developed ex profeso, which participants will be
encouraged to keep as a source of information.
The main themes of group sessions will be: 1) the cli-
macteric stage and the empowerment approach; 2) Emo-
tional well-being, self-esteem and self-efficacy during
menopause; 3) Factors that predispose chronic disease
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related self-care strategies; 4) Physical activity: barriers,
benefits, type, frequency and recommended time. How
to establish an individual action plan on physical activity
and make it feasible (problem solving); 5) Healthy diet
during the climacteric stage including increase of intake
of fruits, vegetables and dairy products on a daily basis,
as well as education about the barriers to and benefits
of a healthy diet. How to establish an individual action
plan toward a healthy diet and make it feasible; 6-8)
Monitoring of the progress of women’s action plans.
Participants should attend to group sessions one to five,
and to sessions six to eight can attend either as a group
or individually.
Data collection
Information on the study variables will be collected on
three occasions: when the woman enters to the study
(baseline), once intervention is complete (at three months)
and after three more months of follow-up (six months).
Study variables
The main outcome variables will be:
Health-related quality of life (HR-QoL), which will be
measured with the revised version of Women’sH e a l t h
Questionnaire (WHQ23) [43]. This is a specific ques-
tionnaire for women in perimenopause, menopause and
post menopause stages, that comprises six domains:
anxiety/depression, well-being, somatic symptoms,
memory/concentration, vasomotor symptoms and sleep
problems. The WHQ23 also has two optional domains:
sexual behavior and menstrual symptoms, which will
apply only to women who are sexually active or who
have menstrual periods. The highest value for each
domain score is 100, which means high HR-QoL, and
the lowest is 0, which means low HR-QoL.
Other outcome variables will be:
1) Empowerment of women in relation to their self-
care measured by the empowerment scale, which was
modified from the diabetes empowerment short scale
[44] to be used in climacteric women. The maximum
score of empowerment is 5, the minimum is 1.
2) Self-efficacy of women in relation to menopause
and its care will be assessed with Perimenopausal Health
Self-efficacy Scale (PHS-ES) which consists of 23 items
[45]. The maximum score of PHS-ES is 207 (high self-
efficacy) and the minimum is 23 (low self-efficacy).
3) Women’s knowledge about the climacteric stage
will be estimated with a questionnaire developed ex pro-
feso. The questionnaire consists of 24 items that assess
the following aspects: what is the climacteric stage, what
are climacteric symptoms and health risks, and how can
they be prevented during the climacteric stage. The
minimum score on the scale corresponds to -24 points
(without knowledge) and the maximum 24 points (full
knowledge).
4) The use of screening services for: a) breast cancer
by mammography in the last two years; b) cervical
Table 2 Individual counseling for climacteric stage women
Steps Content
1) Evaluation of the current status of women (physical,
emotional, cognitive, etc.) within their social environment
￿ The nurse and the woman collaboratively assess the woman’s health and
health-related self-care practices (diet, leisure time physical activity, use of
screening services).
￿ The nurse provides relevant information on climacteric self-care: a) explains
the definition of the climacteric stage and menopause and health problems
the woman may experience during and after the climacteric stage; b)
describe the factors (activities) that cause or protect against the occurrence of
such problems; c) answers the woman’s questions.
2) Facilitation of the woman’s recognition of her personal health
risks and responsibility for health-related self-care
￿ The nurse guides women on specific personal health-related values,
beginning with the question: What health would you like to have in the next
10 years?
3 and 4) Guidance on the health-related goal setting and
elaboration of a feasible action plan for women’s self-care
￿ The nurse guides women to choose their personal health-related self-care
goals.
￿ The nurse guides women to choose strategies/actions to overcome barriers,
using the problem-solving model.
￿ The nurse facilitates the agreement of women to carry out the action plan.
￿ The nurse and women jointly assess the level of womens’ self-efficacy
regarding the achievement of the agreed actions (on a scale of 0 to 10).
5) Monitoring of the progress of the action plan The nurse and women jointly:
￿ Evaluate progress in achieving the health-related goals and specific actions
for development and maintenance of healthy behaviors.
￿ Resolve problems related to barriers for implementing the action plan,
translating such barriers in the “learned lessons.”
Modified from Funnell MM, 2004 to counsel women at the climacteric stage.
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without a history of total hysterectomy; c) diabetes by
measuring fasting plasma glucose in the last three years;
d) hypertension: by measuring the systolic and diastolic
blood pressure in the last year. The use of screening ser-
vices will be estimated as the sum of the number of
screening services that women used, divided by the total
number of screening services recommended according
to IMSS regulations and multiplied by 100.
5) Percentage of women who practice regular leisure
time physical activity (PA), where regular was defined as
moderate intensity if done for ≥150 minutes/week or
vigorous intensity if done ≥75 minutes/week.
6) Percentage of women who practice a healthy diet,
which included the daily consumption of fruits (3-4 ser-
vings), vegetables (4-5 servings), and dairy products (2-3
servings).
The covariates will be:
a) Women’s general characteristics: Age, schooling,
marital and employment status.
b) Smoking status and alcohol consumption. Smoking
status will consider former and current smokers and
will register the number of cigarettes actually smoked
per day. Alcohol consumption will be classified as non-
drinkers (never drink alcohol), occasional drinkers
(drink rarely or less than once a week), moderate drin-
kers (from 1 to 14 drinks per week) and heavy drinkers
(more than 14 drinks per week).
c) Nutritional status will be measured by body mass
index (BMI) and classified into groups of normal weight
(BMI of 18.5-24.9 kg/m
2), overweight (BMI of 25.0 to
29.9 kg/m
2), or obese (BMI ≥30.0 kg/m
2).
d) Social support (SS) will be measured by applying
the DUKE-UNC-11 questionnaire [46]. This question-
naire evaluates confidential SS (possibility of having peo-
p l et oc o m m u n i c a t ew i t h )w i t ham i n i m u ms c o r eo f7
points (low confidential SS) and a maximum score of 35
points (high confidential SS); and affective SS (demon-
stration of love, affection, and empathy) with a mini-
mum score of 4 (low affective SS) and a maximum
score of 20 points (high affective SS).
e) Medical and reproductive history: Presence of chronic
diseases, number of pregnancies and living children, and
menopause (one year after the last menstrual period).
Type of menopause will be classified as natural or surgical,
age at onset of menopause; time elapsed since menopause,
presence and type of climacteric symptoms, and number
of visits with the family doctor or other health provider in
the last three months. The severity of vasomotor symp-
toms and vaginal atrophy symptoms is classified using the
criteria proposed by the Department of Health and
Human Services Food and Drug Administration [47],
which are based upon women’s self-report, and define the
symptoms as mild, moderate, or severe.
f) Satisfaction with care received at the FMC will be
measured with the general question of how satisfied are
you with the care you have received at the clinic? The
possible answers are very satisfied, satisfied, neither
satisfied nor unsatisfied, unsatisfied, and very unsatisfied.
g) Women’s self-esteem will be measured with the
Rosenberg Self-Esteem Scale (EAR) [48,49]. It is a one-
domain instrument that consists of 10 questions. The
highest score is 30 (high self-esteem) and the lowest is 0
(low self-esteem).
h) Adherence to MAIMC will be defined when the
woman attends at least 60% of the planned individual
and group counseling sessions.
Sample size
The sample size for the primary outcome (HR-QoL) was
estimated by using the formula to test change in the
mean of two normally distributed samples in longitudi-
nal studies [50]. An average increase of at least 10
points in one or more domains of WHQ23 in the inter-
vention group compared with control group women was
considered to be clinically relevant. The assumptions
included: a mean HR-QoL score of 64.9 points (standard
deviation of 23.4 points) in the domain of general well-
being [51], a = 0.05 (for one-sided hypothesis) and b =
0.20. The number of women by group, assuming a
drop-out rate of 20% will be 107.
We also estimated a sample size for regular leisure
time physical activity considering that this is the out-
come variable more difficult to achieve. It was assumed
that only 17% of women in Mexico engaged in some
type of regular leisure time physical activity [11] and a
positive increase of at least 10% will be achieved after
women participation in the IHCM. For this calculation,
we used the formula to test the difference of propor-
tions between two populations [50] with a = 0.05 (one
side) and the power of 80%. The total number of
women by group to include assuming a drop-out rate of
20% will be 207.
Statistical analysis
The women characteristics of each intervention and
comparison groups will be compared by using the Chi-
square test to ascertain whether the groups were
equivalent.
The effects of intervention for categorical outcome
variables (regular leisure time physical activity, healthy
d i e t )w i l lb em e a s u r e db yc o m p a r i n gt h eb a s e l i n ea n d
post-intervention evaluation stages for differences in
these variables using Chi-square test. Absolute percen-
tage differences and corresponding 95% confidence
intervals will be calculated.
Scores for the HR-QoL on the WHQ23 scale, the self-
efficacy on the PHS-ES scale, the empowerment on the
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and menopause and self-care-related activities will be
calculated according to the scoring algorithms. Measures
of central tendency and distribution will be examined
for these variables at the different measurement periods.
T h ed i f f e r e n c e si nt h eb a s e l i n ea n dp o s t - i n t e r v e n t i o n
stages for outcome variables will be compared within
each group, and differences between the groups will be
compared using the differences-in-differences (D-in-D)
estimator [52]. The generalized linear model (GLM) will
be used to assess changes in the main outcome variable
controlling for baseline measures and other study vari-
ables as covariates. The GLM methods allow for model-
ing the correlation of the repeated observations on the
same subjects [53].
T h epv a l u e< 0 . 0 5w i l lb ec o nsidered as statistically
significant. The analysis will be performed with the
Stata 11.0 statistical software (Stata 11.0, Stata Corp;
College Station, TX).
Discussion
In primary care services, it is essential to provide a
source of care that has continuity and coordination, and
comprehensively covers the health needs of people. The
constraints resulting from limited resources and restric-
tive organizational characteristics of institutionalized
healthcare allows a limited range of changes, and these
circumstances promote that innovative healthcare mod-
els should be carefully designed and evaluated to
demonstrate healthcare service relevance and feasibility.
Relevance, in this case, refers to meeting the health
needs of climacteric stage women and to demonstrating
its potential benefit. Feasibility means that the new
model of care is applicable in the local context. An inte-
grative health care model (bio-psycho-social, multidisci-
plinary and women-centered) with the empowerment
approach may be a better alternative to ensure that
women engage in their self-care and understand its
importance to their present and future health and qual-
ity of life. The evaluation of the effectiveness of this
research-based model can guide the feasibility of extend-
ing it into an operational model through a specific
program.
The possible limitations of the study may include the
following:
It was decided to perform the intervention in one
clinic, taking another as a control to prevent women
from both groups from communicating and transmitting
information between them. However, the implementa-
tion of the study in two clinics may result in difference
baseline characteristics of women in both groups. To
overcome this limitation in the data analysis step, the
regression methods will be used to adjust the results of
the study for possible differences between groups.
Furthermore, the baseline evaluation can affect women
in the control group resulting in them seeking counsel-
ing regarding the climacteric stage, attending screening
programs, and changing their lifestyles.
The request for voluntary collaboration of family doctors
and women could result in better doctors and women
with healthier lifestyles agreeing to participate. Previous
studies have reported that patients with unhealthy life-
styles are usually reluctant to participate. To confirm or
disregard this limitation we will apply a short list of ques-
tions about the general characteristics and lifestyles to
women who do not agree to participate in the study.
Compliance with the leisure time physical activity and
healthy diet will be assessed through self-reporting of
w o m e nu n a b l et ov e r i f yt h e i ractual practice, and will
possibly overestimate the effect of the intervention
regarding these variables.
Due to budgetary restrictions it is not possible to plan
a long-term follow-up (12 months of study) of the
IHCM impact.
Due to the financial and organizational feasibility, the
study will be tested only in the population covered by
IMSS, therefore, we can not say that this strategy would
have the same results in women affiliated with other
health institutions in Mexico, or women who receive
healthcare from the Ministry of Health. However, we
expect that the results of this study can be implemented
in other institutions, with some necessary adaptations.
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